UK Hemophilia Care Teams Lack Knowledge on Bleeding Risks in Dental Procedures, Study Suggests
Hemophilia care providers in the U.K. have insufficient knowledge on how to assess the risk of prolonged bleeding associated with…
Articles by Alice Melão
Hemlibra Approved in Europe to Prevent Bleeds in Hemophilia A Patients Without Factor VIII Inhibitors
People with severe hemophilia A living in Europe can now receive treatment with Hemlibra (emicizumab-kxwh) to prevent bleeding episodes.
Many Adults, Families Affected by Hemophilia Support Preconception, Prenatal Genetic Screens, Study Finds
More than half of adults who either have hemophilia or are family members affected by the disease support the use…
Different Treatment Strategies May Affect Sports Participation in Hemophilia Patients, Study Suggests
Hemophilia patients who take intermediate‐dose preventive medication may experience more of an age-related decline in sports participation, joint status, and…
FDA Approves Esperoct as Prophylactic Treatment for Hemophilia A, Novo Nordisk Says
Children and adults with hemophilia A in the United States may soon be treated with N8-GP (turoctocog alfa pegol),…
Spark Therapeutics Provides Update on SPK-8011, Other Potential Gene Therapies for Hemophilia
SPK-8011 may be a safe treatment strategy for patients with severe or moderately severe hemophilia A, achieving an overall 97%…
Preliminary Data Further Show MarzAA’s Potential to Prevent Bleedings
Clinical data from the ongoing Phase 2/3 trial data evaluating MarzAA (marzeptacog alfa activated) in patients with Hemophilia A or…
Case Reports Call for Need to Customize Management of AHA for Elderly
Clinical symptoms of acquired hemophilia A in elderly patients can vary widely, a series of six case reports reveals.
Sigilon, MIT Collaborating to Develop Programmable Cell Therapies for Hemophilia, Other Diseases
Sigilon Therapeutics and the Massachusetts Institute of Technology will work together to develop programmable cell therapeutics for the treatment…
Bayer’s rFVIII Replacement Therapy Jivi Approved in Canada for Hemophilia A Patients 12 and Older
Hemophilia A patients age 12 and older who live in Canada now may receive prophylactic (preventive) treatment with…